Treatment of portal hypertension and restoration of liver function using Lornithine phenylacetate

Details for Australian Patent Application No. 2010258888 (hide)

Owner Ocera Therapeutics, Inc. UCL Business PLC

Inventors Jalan, Rajiv; Anderson, Keith

Agent Spruson & Ferguson

Pub. Number AU-A-2010258888

PCT Pub. Number WO2010/144498

Priority 61/185,158 08.06.09 US; 61/296,377 19.01.10 US; 61/240,748 09.09.09 US

Filing date 8 June 2010

Wipo publication date 16 December 2010

International Classifications

A61K 31/195 (2006.01)

A61K 31/19 (2006.01)

A61K 31/192 (2006.01)

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/144498 Priority application(s): WO2010/144498

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258891-Containment systems

2010258875-Chemical modification motifs for miRNA inhibitors and mimetics